ProPhase Labs Current Assets

ProPhase Labs (PRPH) currently reports a current assets of $2.8M as of June 2026. That compares with $25M in the prior-year period — down 88.6% year over year. Use the charts on this page to explore ProPhase Labs's current assets history and peer comparisons.

ProPhase Labs's current assets decreased from $25M to $2.8M — a 88.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ProPhase Labs reported $2.8M in current assets as of June 2026. That compares with $25M in the prior-year period — down 88.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ProPhase Labs, and consider following PRPH for alerts when major investors trade the stock.

ProPhase Labs is classified in the Healthcare sector. On current assets, it currently shows $2.8M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRPH with unrelated industries.